We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A baby laying down.

No Adverse Health Risks From Steroids Used for Pre-Term Birth, Study Finds

A ginger haired woman leaning over the arm of a chair.

Scientists Identify Brain Circuit That Suppresses Appetite During Nausea

Immunotherapy attacking a cancer cell.

Immunotherapy Combination Approved for Non-Muscle Invasive Bladder Cancer

Psilocybin Shows Promise for Treatment-Resistant Depression – But Is It Safe?

Phage Therapies for Multidrug-Resistant Infections Should Consider Host Response

First Use of CRISPR-Cas9 Gene Editing in Kissing Bugs

News

PROMETRIKA Announces the Availability of Pharmacovigilance Services

Company has selected ARISg™ as its service platform.

Poseida Therapeutics Expands into JLABS

Will foster research collaboration with Janssen for development of allogeneic CAR-T therapies.

Perrigo to Acquire Portfolio of Leading OTC Brands from GSK

Demonstrates Perrigo's unique ability to maximize brand value across the Company's leading European distribution network spanning 36 countries.

Accuratus Lab Services Expands Capabilities

Acquisition of the chemistry, manufacturing and controls (CMC) operation of Array Biopharma.

AbbVie, Halozyme Collaborate

The partnership will focus on developing and commercializing products that combine AbbVie’s compounds with Halozyme’s ENHANZE™ drug delivery platform.

Epigenetic Maps of the Human Body’s Major Organs

Researchers have constructed the most comprehensive map yet of methyl groups that influence which genes are expressed and when.

Weighing a Virus

Chemists, led by Mark Bier, have separated and weighed virus particles using mass spectrometry.

New Degradation Proteins Show Route to Cell Survival

Researchers reveal two proteins that induce degradation of certain cell constituents to help cell survival under nutrient-limiting conditions.

LDC and Qurient Close License Agreement on Novel Anti-cancer Compound

Starting point of a broader drug discovery and development alliance.

4SC Presents Final Results from Phase I AEGIS Trial at ASCO

Daily dosage of oral, anti-mitotic Eg5 inhibitor shows good safety and tolerability.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter